|
Conclusion not yet available, evaluation in process.A follow-up will be submitted as soon as the investigation is complete.Oscor inc.Is submitting the above report to comply with 21 cfr part 803, the medical device reporting regulation.The report is based upon information obtained by oscor inc.Which the company may not have been able to investigate or verify prior to the date the report was required by fda.This report does not constitute an admission that the device, oscor inc., or its employees, caused or contributed to the event described in this report.Nor does this report reflect a conclusion by fda, oscor inc., or its employees, that the report constitutes an admission that the device, oscor inc., or its employees caused or contributed to the event described in this report.
|
|
It was reported that after removing the dilator from the sheath the sheath kinked and tore when pulled out, leaving part of the sheath in the blood vessel.When inserted, the sheath is too unstable to enter any target vessel.Remained part of the sheath was removed from the blood vessel without any patient consequence.No additional information is available.
|